{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:54:36Z","timestamp":1792065276146,"version":"4.4.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1990,4,1]],"date-time":"1990-04-01T00:00:00Z","timestamp":638928000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[1990,4]]},"DOI":"10.1007\/bf02243996","type":"journal-article","created":{"date-parts":[[2005,11,14]],"date-time":"2005-11-14T23:48:38Z","timestamp":1132012118000},"page":"459-463","source":"Crossref","is-referenced-by-count":35,"title":["Blockade of acquisition of drug-conditioned place aversion by 5HT3 antagonists"],"prefix":"10.1007","volume":"100","author":[{"given":"E.","family":"Acquas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Carboni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Garau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Di Chiara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF02243996_CR1","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/0028-3908(86)90207-8","volume":"5","author":"PB Bradley","year":"1986","unstructured":"Bradley PB, Engel S, Feniuk W, Fozard IR, Humprey BPA, Middlemiss DN, Mylechorone EJ, Richardson BP, Sexena PR (1986) Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology 5:563\u2013576","journal-title":"Neuropharmacology"},{"key":"BF02243996_CR2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/BF00442245","volume":"97","author":"E Carboni","year":"1989","unstructured":"Carboni E, Acquas E, Leone P, Di Chiara G (1989a) 5HT3 receptor antagonists block morphine- and nicotine- but not amphetamine-induced reward. Psychopharmacology 97:175\u2013178","journal-title":"Psychopharmacology"},{"key":"BF02243996_CR3","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0014-2999(89)90259-8","volume":"164","author":"E Carboni","year":"1989","unstructured":"Carboni E, Acquas E, Frau R, Di Chiara G (1989b) The 5HT3-antagonist ICS 205-930 prevents dopamine release stimulation by morphine, nicotine, ethanol and haloperidol but not amphetamine. Eur J Pharmacol 164:515\u2013519","journal-title":"Eur J Pharmacol"},{"key":"BF02243996_CR4","first-page":"383","volume":"8","author":"P Chopin","year":"1987","unstructured":"Chopin P, Briley M (1987) Animal models of anxiety: the effect of compounds that modify 5-HT neurotransmission. TIPS Reviews 8:383\u2013388","journal-title":"TIPS Reviews"},{"key":"BF02243996_CR5","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1476-5381.1989.tb11821.x","volume":"96","author":"B Costall","year":"1989","unstructured":"Costall B, Kelly ME, Naylor RJ, Onaivi ES, Tyers MB (1989) Neuroanatomical sites of action of 5-HT3 receptor agonist and antagonists for alteration of aversive behaviour in the mouse. Br J Pharmacol 96:325\u2013332","journal-title":"Br J Pharmacol"},{"key":"BF02243996_CR6","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0014-2999(88)90503-1","volume":"146","author":"AR Dumuis","year":"1988","unstructured":"Dumuis AR, Bouhelal M, Sebben A, Bockaert J (1988) A 5HT receptor in the central nervous system, positively coupled with adenylate cyclase, is antagonized by ICS 205-930. Eur J Pharmacol 146:187\u2013188","journal-title":"Eur J Pharmacol"},{"key":"BF02243996_CR7","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/BF00518776","volume":"326","author":"JR Fozard","year":"1984","unstructured":"Fozard JR (1984) MDL 72222, a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors. Naunyn-Schmiedeberg's Arch Pharmacol 326:36\u201344","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"BF02243996_CR8","first-page":"265","volume":"6","author":"ET Iwamoto","year":"1986","unstructured":"Iwamoto ET (1986) Place-aversion conditioned by phencyclidine in rats: development of tolerance and pharmacologic antagonism. Alcohol Drug Res 6:265\u2013276","journal-title":"Alcohol Drug Res"},{"key":"BF02243996_CR9","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1476-5381.1988.tb11489.x","volume":"93","author":"BJ Jones","year":"1988","unstructured":"Jones BJ, Costall B, Domeney AM, Kelly ME, Naylor RJ, Oakley NR, Tyers, MB (1988a) The potential anxiolitic activity of GR3832F, a 5HT3 receptor antagonist. Br J Pharmacol 93:985\u2013993","journal-title":"Br J Pharmacol"},{"key":"BF02243996_CR10","unstructured":"Jones BJ, Oakley NR, Tyers MB (1988b) The anxiolitic activity of GR3832F, a 5HT3 receptor antagonist in the rat and cynomolgus monkey. Br J Pharmacol 90(Suppl.):88P (Abstract)"},{"key":"BF02243996_CR11","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/330746a0","volume":"330","author":"GJ Kilpatrik","year":"1987","unstructured":"Kilpatrik GJ, Jones BJ, Tyers MB (1987) Identification and distribution of 5HT3 receptors in rat brain using radioligand binding. Nature 330:746\u2013748","journal-title":"Nature"},{"key":"BF02243996_CR12","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0014-2999(88)90816-3","volume":"151","author":"M Papp","year":"1988","unstructured":"Papp M (1988) Similar effects of diazepam and the 5-HT3 receptor antagonist ICS 205-930 on place aversion conditioning. Eur J Pharmacol 151:321\u2013324","journal-title":"Eur J Pharmacol"},{"key":"BF02243996_CR13","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/316126a0","volume":"316","author":"BP Richardson","year":"1985","unstructured":"Richardson BP, Engel G, Donatsch P, Stadler PA (1985) Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature 316:126\u2013131","journal-title":"Nature"},{"key":"BF02243996_CR14","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF00431813","volume":"87","author":"C Spyraki","year":"1985","unstructured":"Spyraki C, Kazandjian A, Varonos D (1985) Diazepam-induced place preference conditioning: appetitive and antiaversive properties. Psychopharmacology 87:225\u2013232","journal-title":"Psychopharmacology"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02243996.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02243996\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02243996","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T19:31:54Z","timestamp":1557862314000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02243996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,4]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1990,4]]}},"alternative-id":["BF02243996"],"URL":"https:\/\/doi.org\/10.1007\/bf02243996","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,4]]}}}